| | For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler. |
| 260 | Children aged 6 years or less; |
| | LU Authorization Period: Indefinite |
| 261 | Patients who have a tracheostomy; |
| | LU Authorization Period: Indefinite |
| 262 | Patients with cystic fibrosis in whom nebulizer therapy is indicated; |
| | LU Authorization Period: Indefinite |
| 263 | Patients with severe mental or physical disabilities; |
| | LU Authorization Period: Indefinite |
| 264 | Patients who have previously used nebulizer therapy within the last 12 month period. |
| | LU Authorization Period: Indefinite |
